Home/Filings/4/0001209191-13-050985
4//SEC Filing

Proto Labs Inc 4

Accession 0001209191-13-050985

$PRLBCIK 0001443669operating

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 3:52 PM ET

Size

16.0 KB

Accession

0001209191-13-050985

Insider Transaction Report

Form 4
Period: 2013-11-04
Cleveland Bradley A.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2013-11-05$86.83/sh12,312$1,069,051251,932 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-04$86.57/sh34,987$3,028,825293,512 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-04$87.34/sh1,079$94,240292,433 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-05$85.81/sh28,189$2,418,898264,244 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-04$84.56/sh2,000$169,122343,182 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-11-04$85.68/sh14,683$1,258,083328,499 total(indirect: By Trust)
Footnotes (6)
  • [F1]Sales effected pursuant to Rule 10b5-1 trading plan adopted by the Bradley A. Cleveland Declaration Trust (the "Trust") on August 30, 2013.
  • [F2]Reflects the weighted average price of 2,000 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 4, 2013 with sale prices ranging from $84.01 to $84.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Reflects the weighted average price of 14,683 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 4, 2013 with sale prices ranging from $85.145 to $86.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Reflects the weighted average price of 34,987 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 4, 2013 with sale prices ranging from $86.17 to $87.13 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Reflects the weighted average price of 28,189 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 5, 2013 with sale prices ranging from $85.35 to $86.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]Reflects the weighted average price of 12,312 shares of common stock of Proto Labs, Inc. sold by the Trust in multiple transactions on November 5, 2013 with sale prices ranging from $86.37 to $87.13 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

Proto Labs Inc

CIK 0001443669

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0001443669

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 3:52 PM ET
Size
16.0 KB